Could a natural brain steroid slow Parkinson's? early trial hints at promise
NCT ID NCT06263010
First seen Apr 05, 2026 · Last updated May 21, 2026 · Updated 5 times
Summary
This early-stage trial tested a natural brain chemical called allopregnanolone in 10 people with Parkinson's disease. Participants received weekly infusions for 12 weeks to see if the treatment is safe and well-tolerated, and to check for any signs of improvement on brain scans and symptom scales. The main goal was to see if a larger study is possible, not to prove the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The University of Arizona Clinical & Translational Science Research Center
Tucson, Arizona, 85721, United States
Conditions
Explore the condition pages connected to this study.